Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_assertion type Assertion NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_head.
- NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_assertion description "[The prevalences of FVL and FII G20210A were lower in the study group than in the control group (3.7 versus 6.1% for FVL and 4.6 versus 6.1% for FII respectively); however, the difference was not statistically significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_provenance.
- NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_assertion evidence source_evidence_literature NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_provenance.
- NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_assertion SIO_000772 12042290 NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_provenance.
- NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_assertion wasDerivedFrom befree-2016 NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_provenance.
- NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_assertion wasGeneratedBy ECO_0000203 NP356659.RASc1jRT02cC0VLejgm3SX8PRWpG-rXfZa8J8hYOkVp6A130_provenance.